The Manufacturers Life Insurance Company Makes New $1.87 Million Investment in National Health Investors, Inc. $NHI

The Manufacturers Life Insurance Company bought a new stake in shares of National Health Investors, Inc. (NYSE:NHI) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 24,520 shares of the real estate investment trust’s stock, valued at approximately $1,870,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Renaissance Group LLC boosted its holdings in shares of National Health Investors by 3.8% in the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock valued at $245,000 after buying an additional 117 shares during the period. Captrust Financial Advisors grew its position in shares of National Health Investors by 1.7% during the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock valued at $680,000 after buying an additional 146 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in National Health Investors by 34.3% during the first quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock worth $51,000 after acquiring an additional 160 shares during the period. Assetmark Inc. raised its stake in National Health Investors by 13.5% during the first quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust’s stock worth $110,000 after acquiring an additional 161 shares during the period. Finally, Inspire Investing LLC lifted its holdings in National Health Investors by 3.2% in the first quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust’s stock worth $510,000 after acquiring an additional 198 shares during the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have commented on NHI shares. Wells Fargo & Company decreased their target price on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating for the company in a research note on Tuesday. Deutsche Bank Aktiengesellschaft reduced their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, June 25th. Truist Financial lowered their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Finally, Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $83.57.

National Health Investors Trading Up 0.3%

National Health Investors stock opened at $71.73 on Friday. National Health Investors, Inc. has a 52-week low of $67.94 and a 52-week high of $91.38. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $3.52 billion, a price-to-earnings ratio of 20.73, a PEG ratio of 3.82 and a beta of 0.52. The firm has a 50-day moving average price of $75.51 and a two-hundred day moving average price of $78.25.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. National Health Investors’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Sell-side analysts expect that National Health Investors, Inc. will post 4.76 earnings per share for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.1%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s dividend payout ratio (DPR) is currently 106.36%.

Insider Buying and Selling

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of the business’s stock in a transaction on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the purchase, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 2.70% of the stock is currently owned by corporate insiders.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.